A recent network analysis revealed that TMPRSS2—which is also located on chromosome 21 and is subsequently overexpressed in Down syndrome—may contribute to COVID-19 severity by promoting increased viral entry [55,57]. This evidence concerns the gene TMPRSS2 and Down syndrome.